 Mesomark assay

The Mesomark Assay is an "in vitro" test to monitor and possibly diagnose pleural mesothelioma and peritoneal mesothelioma.Developed by Fujirebio Diagnostics and approved in late January 2007 by the U.S. Food and Drug Administration (FDA), it works by measuring levels of soluble mesothelin-related proteins (SMRPs) released by diseased mesothelioma cells.